பிரணவ் அமின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alembic Pharma s Q1FY22 net profit down 45 per cent at Rs 165 Cr

Alembic Pharma s Q1FY22 net profit down 45 per cent at Rs 165 Cr
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Pranav aminAlembic pharmaceuticalsபிரணவ் அமின்அலெம்பிக் மருந்துகள்

Alembic Pharmaceuticals Ltd Q1FY22 consolidated PAT slides to Rs 164 52 crores

Alembic Pharmaceuticals Ltd Q1FY22 consolidated PAT slides to Rs 164 52 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Pranav aminAlembic pharmaceuticalsAlembic pharmaceuticals ltdTime zoneManaging directorAlembic pharmaceuticals limitedபிரணவ் அமின்அலெம்பிக் மருந்துகள்அலெம்பிக் மருந்துகள் லிமிடெட்நேரம் ஸோந்நிர்வகித்தல் இயக்குனர்அலெம்பிக் மருந்துகள் வரையறுக்கப்பட்டவை

BCA felicitates top performers | Vadodara News

Vadodara: The Baroda Cricket Association (BCA) on Friday organized a prize distribution ceremony for cricketers who performed well in the last four seasons. BCA president Pranav Amin and other office-bearers gave away the awards to the junior as well as senior players. BCA had conducted 17 club tournaments and about 900 club matches in the last four years. On Friday, 54 awards were given for best batsmen, best bowler, best fielder, man of the series besides 17 runners-up trophies too. Out of the 17 tourneys, Reliance Club was champion six times and Sangramsinh Sports Academy and Youth Service Centre won four times. Akota Cricket Club, Bal Bhavan and Kiran More Academy each won the tourney once. Amin said that the cricketing activities took a hit in the past two years but the association is trying to give facilities including indoor practice area and Kotambi stadium to the players.

Pranav aminSangramsinh sports academyAkota cricket clubReliance clubKiran more academyBaroda cricket associationYouth service centreCricket clubBal bhavanபிரணவ் அமின்பரோடா மட்டைப்பந்து சங்கம்மட்டைப்பந்து சங்கம்பால் பவன்

Companies being roped in to make the injectable drug - The Hindu BusinessLine

Companies being roped in to make the injectable drug May 20, 2021 The Centre gives nod to five more drug companies to produce Amphotericin B More domestic drugmakers have joined the brigade to produce Amphotericin B that is used to treat Mucormycosis (black fungus), and the shortages being reported in parts of the country are expected to ease in a fortnight. The Centre has granted new drug approvals to five more drug companies for producing the injectable Amphotericin B in India, adding to the six companies that are already producing it. In fact, Union Minister of State for Chemicals Mansukh Mandaviya tweeted, “Black Fungus (Mucormycosis) curing drug #Amphotericin B’s shortage will be resolved soon!” Further, he added, “Indian companies have also placed orders for importing 6 lakh vials of Amphotericin B.”

Uttar pradeshSun pharmaRakesh bamzaiA sun pharmaPranav aminGufic biosciencesMansukh mandaviyaNatco pharmaAlembic pharmaceuticalsVaccines ltdLyca pharmaceuticalsIntas pharmaceuticalsEmcure pharmaceuticalsIndian medical associationUnion ministerChemicals mansukh mandaviya

Alembic Pharma share slips 5% after Q4 earnings- Business News

Alembic Pharma share slips 5% after Q4 earnings For FY21, the company posted a net profit of Rs 1178 crore compared to Rs 829 crore in the previous year, up 42 per cent BusinessToday.In | May 5, 2021 | Updated 15:49 IST Representative Image Share of Alembic Pharma declined over 5 per cent in early trade today after the company reported earnings for the quarter ended March 2021. The stock hit an intraday low of Rs 948 and an intraday high of Rs 1,003. The company reported a net profit of Rs 251 crore for Q4 FY21 compared to Rs 225 crore for the corresponding quarter of the previous year, an increase of 11.5 per cent.

Pranav aminInternational businessAlembic pharmaceuticalsUs food drug administrationAlembic pharmaManaging directorPharmaceuticals limitedDrug administrationAbbreviated new drug applicationTimolol maleate ophthalmic solutionLembic pharma stockAlembic pharma sharesLembic pharma shareS fdaMarch quarter earningsபிரணவ் அமின்